BiomX (PHGE) Other Operating Expenses (2018 - 2025)
BiomX (PHGE) posted Other Operating Expenses of -$4.5 million for Q3 2025, up 30.35% sequentially from -$6.5 million in Q3 2024, and up 30.35% YoY from -$3.5 million in Q3 2024.
BiomX (PHGE) Other Operating Expenses (2018 - 2025) Analysis & Trends
BiomX has reported Other Operating Expenses for 5 years, with the latest figure at -$4.5 million in Q3 2025.
- Quarterly Other Operating Expenses rose 30.35% year-over-year to -$4.5 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$4.5 million (up 30.35% YoY) and the FY2019 annual result came in at $404521.0, changed N/A from the prior year.
- Other Operating Expenses rose to -$4.5 million in Q3 2025 per PHGE's latest filing, from -$6.5 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at -$4.5 million in Q3 2025 and troughed at -$6.5 million in Q3 2024.
- A 3-year average of -$5.6 million and a median of -$5.6 million in 2023 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 30.35% in 2025, down 30.35% in 2025.
- Over 3 years, Other Operating Expenses stood at -$5.6 million in 2023, then retreated by 15.36% to -$6.5 million in 2024, then jumped by 30.35% to -$4.5 million in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$4.5 million, -$6.5 million, and -$5.6 million for Q3 2025, Q3 2024, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4.53 Mn |
| Sep 30, 2024 | -6.51 Mn |
| Mar 31, 2023 | -5.64 Mn |
| Sep 30, 2019 | -4.25 Mn |
| Mar 31, 2019 | -1.18 Mn |
| Dec 31, 2018 | 16,439.00 |
| Sep 30, 2018 | 650.00 |
| Jun 30, 2018 | 1,025.00 |
| Mar 31, 2018 | 1,000.00 |